Skip to main content
BioMedli
BioMedli
BiomarkersProtocolsBlogPricing
Log in
Biomarkers / Prostate Specific Antigen (PSA)
Extended coveragenumeric result

Prostate Specific Antigen (PSA)

Prostate Specific Antigen (PSA) is a laboratory measurement commonly reviewed in the context of sex hormones and changes across results over time.

BioMedli support

Read from uploaded lab PDFs

Common stored unit: ng/mL

On this page

OverviewClinical ImportanceResult InterpretationTesting GuideTechnical Details

What is Prostate Specific Antigen (PSA)?

Prostate Specific Antigen (PSA) is a protein produced by cells in the prostate gland, both normal and cancerous. It's an enzyme, a type of protein that speeds up chemical reactions, specifically involved in semen liquefaction after ejaculation.

Prostate gland function

The prostate gland is a small gland in the male reproductive system, located below the bladder, that contributes fluid to semen. PSA is secreted into the ducts of the prostate and then makes its way into the seminal fluid. While its exact physiological role in semen is still being researched, it's believed to help improve sperm motility by breaking down the seminal coagulum.

Circulating in the bloodstream

A small amount of PSA normally leaks from the prostate into the bloodstream. For this reason, PSA is often referred to as a tumor marker, although it's important to understand that elevated PSA levels do not always indicate cancer. It is measured in the blood as a total amount (Total PSA) which includes PSA bound to other proteins and free PSA that is not bound.

Key indicator for prostate health

As a biomarker, PSA is primarily used to monitor prostate health and screen for prostate cancer. Changes in PSA levels can provide valuable information about the state of the prostate gland, prompting further investigation when necessary.

Why is Prostate Specific Antigen (PSA) important?

Prostate Specific Antigen (PSA) is a protein predominantly produced by the prostate gland and found in the blood. It serves as a key indicator for prostate health, with its levels providing insights into the condition of the gland. While it can be elevated for various non-cancerous reasons, significant changes in PSA are crucial for monitoring and early detection.

When levels drop too low

There isn't a defined 'too low' level for PSA that typically causes concern in the same way as high levels. In the context of screening, persistently very low or undetectable PSA levels in men without a history of prostate cancer are generally not a cause for alarm. However, a significant drop in PSA after treatment for prostate cancer can be a positive sign of treatment effectiveness.

When levels climb too high

Elevated PSA levels can be a signal that warrants further investigation. This is because increased PSA can be associated with benign prostatic hyperplasia (BPH), an enlarged prostate that is common in older men, or prostatitis, inflammation of the prostate. Most importantly, elevated PSA can also be an indicator of prostate cancer. The rate at which PSA levels rise over time (PSA velocity) can also be a factor in assessing risk.

The long view on Prostate Specific Antigen

Monitoring PSA levels over time is essential for understanding individual trends and detecting subtle changes that might otherwise go unnoticed. For individuals diagnosed with prostate cancer, PSA serves as a vital tool for monitoring treatment response and detecting recurrence. For those without cancer, it helps in the proactive management of prostate health, allowing for timely interventions if issues arise.

What do my Prostate Specific Antigen (PSA) results mean?

Low PSA levels

Low Prostate Specific Antigen (PSA) levels, typically below 4 ng/mL, are generally considered within the normal range for most men and are not usually indicative of prostate cancer. However, it's important to consider that some prostate cancers may produce low PSA levels. In the context of prostate cancer treatment, a very low or undetectable PSA is often a goal.

Optimal PSA levels

Defining 'optimal' PSA levels is complex and depends heavily on age and individual health history. For younger men, lower levels are generally preferred. As men age, slightly higher PSA levels may be considered within a normal range, but a rapid increase over time is more concerning than a specific number. Many clinicians use a threshold of 4 ng/mL as a point for further discussion, but personalized interpretation is key.

High PSA levels

High PSA levels, especially when rising rapidly, can suggest a problem with the prostate gland. This could include benign conditions such as prostatitis (inflammation) or benign prostatic hyperplasia (BPH, an enlarged prostate). It can also be an indicator of prostate cancer. It is crucial to discuss any elevated PSA results with a healthcare provider for appropriate evaluation.

Factors that influence PSA results

Several factors can influence PSA levels besides prostate cancer. These include age (PSA naturally increases with age), race (higher levels are sometimes seen in African American men), ejaculation (can temporarily increase PSA), inflammation or infection of the prostate, recent medical procedures involving the prostate (like a digital rectal exam or biopsy), and certain medications. It's essential to inform your healthcare provider about any of these factors when interpreting your PSA results.

Do I need a Prostate Specific Antigen (PSA) test?

Are you experiencing urinary changes like increased frequency, difficulty starting or stopping urination, or a weak stream? Could these symptoms, or a family history of prostate issues, indicate a need to monitor your prostate health?

Prostate Specific Antigen (PSA) testing measures the amount of PSA in your blood, providing a valuable marker for the health of your prostate gland. It helps in the early detection of potential prostate issues, including inflammation, enlargement, and cancer.

Understanding your PSA levels empowers you to have informed discussions with your healthcare provider about your prostate health. This knowledge is crucial for personalized screening strategies and proactive management, allowing for timely interventions and peace of mind.

Technical & PDF Reading Details

Measurement context

Units, methods, and reference intervals can differ by laboratory. BioMedli preserves the reported unit and reference context so results can be reviewed against their source report.

How PDF reading works

Extract the numeric value, comparator when present, unit, date, and printed reference interval.

Names a report may use

PSA (Total)PSATotal PSAProstate Specific AntigenPSA, TotalTotal PSA,

Educational context only

BioMedli organizes laboratory information and trends. It does not diagnose disease, define a personal target, or replace a qualified healthcare professional.

Related biomarkers

Free TestosteroneTestosterone, BioavailableTestosterone, TotalDHEA-Sulfate (DHEA-S)Testosterone-to-Estradiol Ratio (T/E₂)Albumin
Upload a report
Illustrated BioMedli health journey with lab reports, mountains, flowers, and people exploring health data

Private health intelligence

Make every lab report part of the story.

BioMedli turns scattered PDF lab reports into a private, searchable health timeline built for trends, protocols, and better questions at your next appointment.

Read yourselfExplore sample dashboard
BioMedli
BioMedli

A privacy-first lab report timeline for people who want to understand what changed, what matters, and what to retest next.

PDF parsingBiomarker trendsPrivate by default
BioMedli - Your longitudinal health intelligence layer | Product Hunt

Product

  • How It Works
  • Features
  • Biomarkers
  • Protocols
  • Pricing
  • Changelog

Learn

  • About
  • Upload Guide
  • Blog
  • Help Center
  • Safety
  • Contact

Legal

  • Privacy
  • Terms
  • Conditions
  • Cookie Policy
  • Refund Policy

© 2026 Terramedici LifeSciences LLP. All rights reserved.

BioMedli is an educational tool, not a diagnostic device, medical provider, or emergency service. Always consult with a qualified healthcare professional for clinical decisions.